Search results
Added:
3 years ago
The yearly incidence of stroke in patients with atrial fibrillation (AF) is approximately 5%,1 which is five times higher than in comparable populations in sinus rhythm (SR). The stroke risk largely depends on the underlying heart disease. In 'lone' AF (absence of heart disease) the stroke risk is only 0.5% per year,2 whereas in AF associated with rheumatic valvular heart disease (VHD), like…
View more
Added:
3 years ago
Stroke is the second most common cause of mortality worldwide and the third most common cause of disability.1 Although there has been a global trend towards a reduction in stroke incidence, prevalence and mortality since the 1990s, the overall stroke burden in terms of absolute number of people affected continues to increase.2 More than 1 million people have a stroke every year in Europe and that…
View more
Added:
3 years ago
The yearly incidence of stroke in patients with atrial fibrillation (AF) is approximately 5%, which is five times higher than in comparable populations in sinus rhythm (SR). The stroke risk largely depends on the underlying heart disease. In 'lone' AF (absence of heart disease) the stroke risk is only 0.5% per year, whereas in AF associated with rheumatic valvular heart disease (VHD), like mitral…
View more
Added:
3 years ago
Aetiological Classification of Stroke
Precise analysis of stroke subtypes is important for clinical treatment decisions and prognostic evaluation of patients leading to adapted individual patient management. The most widely used system of aetiological ischaemic stroke classification is the Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification, proposed in 1993 for an acute stroke…
View more
New Stroke Outcomes Data: The Role of Prolonged Cardiac Monitoring in Secondary Stroke Prevention
Start date:
Oct 09, 2019
Broadcast
Added:
2 years ago
In this interview, Dr Henrik Bjursten (Lund University Hospital, Lund, SE) discusses the findings of a nationwide retrospective study evaluating the risk of stroke after TAVI procedures in Swedish patients.
Questions:
What was the rationale behind this study?
What was the design, patient cohort and endpoints?
How did you define stroke in this study?
What were the key findings?
What conclusions…
View more
Added:
3 years ago
At least 795,000 people suffer a new or recurrent stroke each year in the US.1 Every 40 seconds, someone in the US has a stroke, and stroke is the third leading cause of death in the US.1 These numbers are likely to increase as the US population ages and as stroke awareness increases. In the past, ischaemic stroke has been managed with palliation and rehabilitation and with prevention of the…
View more
Added:
1 year ago
ESC Congress 22 — Prof Ashkan Shoamanesh (McMaster University, CA) reveals the findings of the PACIFIC-STROKE trial (NCT04304508). This multicenter study aims to find the best dose of oral FXIa inhibitor, asundexian (Bayer). 1808 patients with non-cardioembolic ischemic stroke were included in this trial, and were randomized to receive different doses of asundexian.
Questions:
What doses were…
View more
Added:
5 years ago
Prof Julia Machline Carrion discusses The Bridge Stroke Trail at AHA 2018 - An international cluster randomized quality-improvement trial to increase the adherence to evidence based therapies for acute ischemic stroke and transient ischemic attack patients.
Filmed by Radcliffe Cardiology at AHA 2018
View more
Start date:
Feb 07, 2024
End date:
Feb 09, 2024
Register Now!Join us for the International Stroke Conference 2024 in Phoenix, Arizona. This is your opportunity to:Network with fellow professionals.Stay updated on the latest treatments and scientific breakthroughs.Collaborate with global experts.Dive into discussions on brain health, stroke recovery, and more.Don't miss out! Register today and be part of ISC 2024.Find the online program planner…
View more
